By Shane Stokes in Brest
The ten member teams of the MPCC (Movement for a Credible Cycling) which will ride the Tour de France met on Friday in Brest, and confirmed that none of their riders has had oral or injectable use of corticoids in the 15 days leading up to the race.
According to a MPCC press release, the health booklets of those from AG2R, Agritubel, Bouygues Telecom, Cofidis, Columbia, Crédit Agricole, Française des Jeux, Garmin Chipotle, Gerolsteiner and Rabobank have been verified by an independent doctor as clear in this regard. Another verification of the booklets will be made at the end of the race.
The doctors of the MPCC teams have formally requested WADA and the UCI to continue to require TUEs for corticoid use. They also request that any infiltration of corticoids (injection or oral) should be followed by a 15-day break from competition.
